Literature DB >> 656272

Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.

A Gulaid, I M James, C M Kaye, O R Lewellen, E Roberts, M Sankey, J Smith, R Templeton, R J Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 656272      PMCID： PMC1429267          DOI： 10.1111/j.1365-2125.1978.tb01634.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  HUMAN ACETYLATION POLYMORPHISM.

Authors:  D A EVANS; T A WHITE
Journal:  J Lab Clin Med       Date:  1964-03

2.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

3.  High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metabolite.

Authors:  P J Meffin; S R Harapat; Y G Yee; D C Harrison
Journal:  J Chromatogr       Date:  1977-08-01

4.  An improved and simplified method of detecting the acetylator phenotype.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1969-12       Impact factor: 6.318

5.  Acebutolol metabolite plasma concentration during chronic oral therapy.

Authors:  R A Winkle; P J Meffin; W B Ricks; D C Harrison
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 6.  Variations between individuals and populations in the acetylation of isoniazid and its significance for the treatment of pulmonary tuberculosis.

Authors:  G A Ellard
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

7.  Antiarrhythmic potency of N-acetylprocainamide.

Authors:  J Elson; J M Strong; W K Lee; A J Atkinson
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

8.  Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man.

Authors:  P F Meffin; S R Harapat; D C Harrison
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-09

9.  Acetylator phenotype in patients with hydralazine-induced lupoid syndrome.

Authors:  I Strandberg; G Boman; L Hassler; F Sjöqvist
Journal:  Acta Med Scand       Date:  1976

10.  Spontaneous systemic lupus erythematosus and acelylator phenotype.

Authors:  R Larsson; E Karlsson; L Molin
Journal:  Acta Med Scand       Date:  1977
View more
  5 in total

1.  Acebutolol in hypertension: relationships between drug concentration and effects.

Authors:  M A Martin; F C Phillips; G T Tucker; A J Smith
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

Review 3.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

4.  Antihypertensive effect of diacetolol in essential hypertension.

Authors:  M Thibonnier; C Flabeau; M Thouvenin; A Roux; B Flouvat; P Pasquier; J Menard
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.

Authors:  K Ohashi; S J Warrington; C M Kaye; G W Houghton; M Dennis; R Templeton; P Turner
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.